• Description: Amarillo Biosciences, Inc. (Abi) is engaged in developing biologics for the treatment of human and animal diseases. The Company is focusing its research on human health indications for the use of low-dose orally administered natural human interferon alpha, particularly for the treatment of Sjogren's syndrome, Behcet's disease, polycythemia vera, essential thrombocythemia, idiopathic pulmonary fibrosis and oral warts in human immunodeficiency virus-positive (Hiv+) patients. Abi owns or licenses 15 United States patents relating to the use or composition of low-dose oral natural interferon alpha. Amarillo Biosciences, Inc. is a biotechnology company that specializes in the research and development of utilization of low-dose, orally administered interferon as a treatment for various conditions comprising chronic cough, influenza, and opportunistic infections in patients who are HIV positive. General Information Year established 1994
    • More Products No Keyword available...
    • Description: No description available...
    • More Products No Keyword available...
    • Description: No description available...
    • More Products No Keyword available...
    • Description: No description available...
    • More Products No Keyword available...
    • Description: No description available...
    • More Products No Keyword available...
    • Description: Bentec Scientific, LLC manufactures acrylonitrile styrene acrylic, acrylonitrile styrene acrylic alloys, fluoropolymers and liquid crystal polymer.
    • More Products No Keyword available...
    • Description: No description available...
    • More Products No Keyword available...
    • Description: Safeguard Scientifics, Inc. (Safeguard) is a provider of growth capital, as well as a range of strategic, operational and management resources to its partner companies. Safeguard participates in expansion financings, carve-outs, management buy-outs, recap Safeguard Scientifics, Inc, is a provider of capital, strategic, operational and management resources to their partner companies. The company invests in high-tech and life sciences ventures, often for the long haul. It provides capital, strategic advice, and operational support for expansion, management buyouts, recapitalizations, and consolidations. General Information Year established 1953
    • More Products No Keyword available...
    • Description: SIGA Technologies, Inc. is a development-stage biotechnology company engaged in discovering, developing and commercializing vaccines, antibiotics and novel anti-infectives for serious infectious diseases. The Company's lead vaccine candidate is for the prevention of group A streptococcal pharyngitis (strep throat). The Company is developing a technology for the mucosal delivery of its vaccines, which may allow those vaccines to activate the immune system at the mucus-lined surfaces of the body, such as the mouth, the nose, the lungs and the gastrointestinal and urogenital tracts, which are the sites of entry for most infectious agents. The Company focuses its anti-infectives program on the increasingly serious problem of drug resistance. These programs are designed to block the ability of bacteria to attach to human tissue, the first step in the infection process. The Company's technologies are licensed from third parties. SIGA Technologies, Inc, is a bio-defense company that discovers, develops and commercializes products for defense against biological warfare agents, such as smallpox and arenaviruses. The company also discovers and develops anti-infectives, vaccines, and antibiotics for prevention and treatment of serious infectious diseases. General Information Year established 1995
    • More Products No Keyword available...
    • Description: No description available...
    • More Products No Keyword available...

Silver Banners